PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 66 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $195 | -42.3% | 11,720 | -4.1% | 0.02% | -41.4% |
| Q2 2023 | $338 | +20.3% | 12,220 | 0.0% | 0.03% | +11.5% |
| Q1 2023 | $281 | -39.0% | 12,220 | -71.1% | 0.03% | -40.9% |
| Q4 2022 | $461 | -99.9% | 42,220 | 0.0% | 0.04% | +22.2% |
| Q3 2022 | $356,000 | +6.6% | 42,220 | 0.0% | 0.04% | +12.5% |
| Q2 2022 | $334,000 | -36.5% | 42,220 | +90.0% | 0.03% | -23.8% |
| Q1 2022 | $526,000 | -30.8% | 22,220 | 0.0% | 0.04% | -26.3% |
| Q4 2021 | $760,000 | +92.9% | 22,220 | 0.0% | 0.06% | +72.7% |
| Q3 2021 | $394,000 | -56.7% | 22,220 | +9.7% | 0.03% | -57.1% |
| Q2 2021 | $909,000 | +57.8% | 20,250 | -9.0% | 0.08% | +45.3% |
| Q1 2021 | $576,000 | +28.3% | 22,250 | 0.0% | 0.05% | +20.5% |
| Q4 2020 | $449,000 | +3.2% | 22,250 | 0.0% | 0.04% | -6.4% |
| Q3 2020 | $435,000 | +5.8% | 22,250 | -4.5% | 0.05% | -4.1% |
| Q2 2020 | $411,000 | +147.6% | 23,300 | -0.9% | 0.05% | +104.2% |
| Q1 2020 | $166,000 | 0.0% | 23,500 | 0.0% | 0.02% | +20.0% |
| Q4 2019 | $166,000 | -41.1% | 23,500 | 0.0% | 0.02% | -44.4% |
| Q3 2019 | $282,000 | -1.1% | 23,500 | 0.0% | 0.04% | -2.7% |
| Q2 2019 | $285,000 | -3.4% | 23,500 | 0.0% | 0.04% | -9.8% |
| Q1 2019 | $295,000 | +86.7% | 23,500 | 0.0% | 0.04% | +64.0% |
| Q4 2018 | $158,000 | -43.2% | 23,500 | -13.0% | 0.02% | -34.2% |
| Q3 2018 | $278,000 | +51.9% | 27,000 | -1.1% | 0.04% | +40.7% |
| Q2 2018 | $183,000 | -54.4% | 27,300 | -41.5% | 0.03% | -55.0% |
| Q1 2018 | $401,000 | -58.7% | 46,700 | 0.0% | 0.06% | -58.6% |
| Q4 2017 | $971,000 | +229.2% | 46,700 | +179.6% | 0.14% | +202.1% |
| Q3 2017 | $295,000 | – | 16,700 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $67,646,434 | 21.00% |
| COWEN AND COMPANY, LLC | 1,657,551 | $45,781,558 | 3.80% |
| Kynam Capital Management, LP | 975,298 | $26,937,731 | 3.70% |
| BVF INC/IL | 3,775,900 | $104,290,358 | 2.91% |
| RTW INVESTMENTS, LP | 5,415,514 | $149,576,497 | 2.85% |
| Cormorant Asset Management, LP | 1,500,000 | $41,430,000 | 2.32% |
| Ghost Tree Capital, LLC | 225,000 | $6,214,500 | 2.05% |
| 683 Capital Management, LLC | 814,000 | $22,482,680 | 1.62% |
| Perceptive Advisors | 1,469,761 | $40,594,799 | 1.18% |
| Artia Global Partners LP | 112,340 | $3,102,831 | 1.07% |